Immunocore reports fourth quarter and full year 2025 financial results and provides a business update KIMMTRAK (tebentafusp-tebn) Q4 net sales ...

An international team of researchers has forced light to replicate the quantum Hall effect, a Nobel Prize–winning phenomenon that, until now, belonged almost exclusively to electrons moving through ...

Alzheimer's disease (AD) is the most common neurodegenerative disorder, characterized by progressive cognitive decline and ...

Anifrolumab may induce earlier and potentially more meaningful immunologic changes in lupus nephritis than can be captured through proteinuria-based endpoints alone.

Explore how proteomics transforms pharmaceutical R&D, from drug discovery to biomarker qualification and clinical development ...

Demyelinating diseases, including multiple sclerosis (MS) and Charcot-Marie-Tooth (CMT) disease, present a substantial and escalating burden. | Demyelinating diseases, including multiple sclerosis (MS ...

This is a sponsored article brought to you by Audio Precision. Bluetooth started as a simple wireless connection between a phone and a headset.

Palatin Technologies, Inc. , a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor (MCR) system, today announced ...

Sourabh Raaj Jain opens up about balancing OTT, theatre and radio simultaneously, and why this phase feels like a fresh acting classroom for him.

Priority Setting Partnership aimed to identify and prioritise unanswered questions important to adult patients, their families and health professionals with lived experience of critical care across ...

EET Espoo, Finland, March 5, 2026: Herantis Pharma Plc ("Herantis") a clinical-stage company developing disease-modifying therapies to stop the progression of Parkinson’s disease, releases today the ...

In the Phase 2/3 COMPANION-002 study of tovecimig (DLL4 x VEGF-A bispecific antibody) in patients with biliary tract cancer, the prespecified ...